Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy
about
Taurine: the appeal of a safe amino acid for skeletal muscle disordersPre-clinical drug tests in the mdx mouse as a model of dystrophinopathies: an overviewMulti-parametric MRI at 14T for muscular dystrophy mice treated with AAV vector-mediated gene therapyLow intensity, high frequency vibration training to improve musculoskeletal function in a mouse model of Duchenne muscular dystrophyNutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the ConjecturePathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focusIsobaric Tagging-Based Quantification for Proteomic Analysis: A Comparative Study of Spared and Affected Muscles from mdx Mice at the Early Phase of DystrophyThreats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experimentsP2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophyPhosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusion.Exercise training improves plantar flexor muscle function in mdx mice.Three-dimensional optical coherence micro-elastography of skeletal muscle tissue.Loss of IL-15 receptor α alters the endurance, fatigability, and metabolic characteristics of mouse fast skeletal muscles.Cognitive and behavior deficits in sickle cell mice are associated with profound neuropathologic changes in hippocampus and cerebellum.Age- and gender-related changes in contractile properties of non-atrophied EDL muscleβ1-syntrophin modulation by miR-222 in mdx mice.A Reduction in Selenoprotein S Amplifies the Inflammatory Profile of Fast-Twitch Skeletal Muscle in the mdx Dystrophic Mouse.Antibody-directed myostatin inhibition improves diaphragm pathology in young but not adult dystrophic mdx mice.Proteomic Profiling of the Dystrophin-Deficient MDX Heart Reveals Drastically Altered Levels of Key Metabolic and Contractile Proteins.Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin.Options for tracking GFP-Labeled transplanted myoblasts using in vivo fluorescence imaging: implications for tracking stem cell fateSelective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx micePreclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures.The different impact of a high fat diet on dystrophic mdx and control C57Bl/10 micePharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trialsVoluntary wheel running in dystrophin-deficient (mdx) mice: Relationships between exercise parameters and exacerbation of the dystrophic phenotypeIL-6 signaling blockade increases inflammation but does not affect muscle function in the mdx mouse.Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissuesLong-term blocking of calcium channels in mdx mice results in differential effects on heart and skeletal muscleThe effects of glucocorticoid and voluntary exercise treatment on the development of thoracolumbar kyphosis in dystrophin-deficient mice.A new web-based method for automated analysis of muscle histologyDelta-like 1 homolog (dlk1): a marker for rhabdomyosarcomas implicated in skeletal muscle regeneration.Changes in muscle T2 and tissue damage after downhill running in mdx mice.Gender influences cardiac function in the mdx model of Duchenne cardiomyopathy.Effects of Dantrolene Therapy on Disease Phenotype in Dystrophin Deficient mdx Mice.Dystropathology increases energy expenditure and protein turnover in the mdx mouse model of duchenne muscular dystrophyHigh-fat diet causes bone loss in young mice by promoting osteoclastogenesis through alteration of the bone marrow environment.Wild-type mouse models to screen antisense oligonucleotides for exon-skipping efficacy in Duchenne muscular dystrophy.mdx(⁵cv) mice manifest more severe muscle dysfunction and diaphragm force deficits than do mdx MiceAssessment of aged mdx mice by electrical impedance myography and magnetic resonance imaging.
P2860
Q26799770-31B82B1C-D914-4E98-BE7A-1A6B026A7C02Q26849430-6E90E08F-EC54-438F-B1FD-5F748E2667A5Q27308877-337BD11E-DBAE-4482-B164-01BD0C11E504Q27316168-436840E7-94B7-4956-8114-6B6514CE40EAQ28072269-3CE73A19-9063-4E07-9B1C-95704E91A808Q28087567-EF20D2D1-F66F-4181-A05D-643524988DCEQ28534074-9E20485A-7D45-4B3E-A96A-9CC05EA7AF07Q28534767-CA063B35-171D-4756-B746-C29F1CE773B4Q28550201-2A09717A-E502-4D7C-A0AF-65DF9FB62863Q30416374-5A9FAC1D-2F39-4BD8-85AB-8F8D139B90EAQ30417474-E1412B21-DE64-4313-BEC5-7DF5179A3C92Q30426112-5A0A3A66-564A-4C53-B7FB-170A630F9C00Q30503154-CF4A7165-9ADB-483D-A389-76EBB459892BQ30691983-B84EBFF0-A65F-478E-8F3E-666384C23B6BQ33680318-BBE6FE30-7FA7-4D1C-B09D-1A14ECA65092Q33697991-E98199CA-0D9D-4631-BCE1-29C7876BF941Q33737817-B9C0B18F-0E52-4FFC-9267-5D9F35A52EE3Q33816426-0C04FDEF-5DFE-4FF0-9FE1-A592F4E0601FQ33871052-B6BC91D5-ACA0-455D-9111-7AC24CBD4206Q33891300-F1B938C3-56F7-4EF3-A882-D6D7F5632B71Q33898074-4D0F5503-E3BF-4F71-9FC8-A63B144A253CQ33925571-19B7E4B8-96BB-4DE2-8C1F-71D26FCEB338Q33975979-5E7003B5-9000-4A0A-BCC4-17B73D4216D2Q34077151-8F4C4817-6D55-4C3A-93E0-43C3B2951EFFQ34152280-7CCA9015-D5D7-49EE-B8A3-EA8163EDF7F6Q34212264-0A9E8559-330B-4542-ABF8-F668D10A88BDQ34310898-16AB2AEF-2F9B-42E8-B6EE-268EB7B165EBQ34333323-FABE30E6-075D-4DA5-B274-51EC7E63BD8AQ34469185-7417BB09-D752-4236-B91A-9AC29B561B57Q34474684-5B90239D-92E0-44D6-8BF3-B9599D8B22E6Q34550000-D5751E2A-EF41-4F6A-99E5-11CD0CCE77A9Q34663937-39E94B1F-6138-47F9-B371-EDBE4561EBABQ35004551-62CA4D07-69F0-4AC7-8B28-9D83E75C7D1FQ35027808-C36092BE-32EC-4246-A85D-69CAF353F8AFQ35051963-68A83AA3-8216-436C-8B66-D2C7199518FAQ35106988-0A3154E4-D617-4F90-B797-B821266A68B8Q35247362-0D4A003A-2BFC-4FC1-8E28-DDAE935569EAQ35388411-8AECAEFC-1B5C-4131-8EDB-CE4BB8098542Q35474357-0F19B7C3-A0EB-4514-AC76-DB2AA94F02BFQ35544348-D448EEC7-6555-4AA5-B07A-D9CDD27F56AA
P2860
Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Towards developing standard op ...... of Duchenne muscular dystrophy
@en
type
label
Towards developing standard op ...... of Duchenne muscular dystrophy
@en
prefLabel
Towards developing standard op ...... of Duchenne muscular dystrophy
@en
P2860
P50
P1476
Towards developing standard op ...... of Duchenne muscular dystrophy
@en
P2093
Hannah G Radley
P2860
P356
10.1016/J.NBD.2008.03.008
P577
2008-04-09T00:00:00Z